# Blue Owl Capital Holdings LP 13F Q2 2026: $665 million

Blue Owl Capital Holdings LP reported $665 million in 13F securities across 76 positions for the quarter ended June 30, 2026, in a holdings report filed August 11, 2026. Its largest holding was Space Exploration Techn Corp at $239 million, 36.0% of the reported value. Since Q1 2026 it opened 23 new positions and exited 22.

SpecStream is the live web data engine for teams and agents. It reads the SEC's Form 13F data sets each quarter, and this page is that reading, keyed on the manager's CIK and the security's CUSIP. Ask for the managers or the holdings you track, and each new 13F filing arrives in your sheet, CRM, Slack or agent as the SEC publishes it.

- Quarter: Q2 2026, the quarter ended June 30, 2026
- Reported value: $664,512,435
- Positions: 76
- Filed: August 11, 2026
- Report type: 13F holdings report
- CIK: 1858703
- Form 13F file number: 028-21866
- Business address: 399 Park Avenue, New York, NY 10022
- SEC filing: [0001193125-26-345031](https://www.sec.gov/Archives/edgar/data/1858703/000119312526345031/0001193125-26-345031-index.htm)

## Top 25 holdings by value

The largest of 76 positions by reported value at the end of the quarter ended June 30, 2026. Put and call options are marked in the class. Change is in shares or principal against the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value | Change since Q1 2026 |
| --- | --- | --- | --- | --- |
| [Space Exploration Techn Corp](https://specstream.ai/data/institutional-holders/space-exploration-techn-corp-84615q103) | CLASS A COM STK | 1,398,815 | $239 million | New |
| [Aktis Oncology Inc](https://specstream.ai/data/institutional-holders/aktis-oncology-inc-01021m104) | COM | 3,070,219 | $99 million | -91,129 |
| [Cullinan Therapeutics Inc](https://specstream.ai/data/institutional-holders/cullinan-therapeutics-inc-230031106) | COM | 1,539,764 | $28 million | -370,000 |
| [Larimar Therapeutics Inc](https://specstream.ai/data/institutional-holders/larimar-therapeutics-inc-517125100) | COM | 9,163,157 | $27.9 million | +2,043,150 |
| [Nuveen Churchill Direct Lend](https://specstream.ai/data/institutional-holders/nuveen-churchill-direct-lend-67090s108) | COM SHS | 2,143,626 | $26.6 million | No change |
| [Maplight Therapeutics Inc](https://specstream.ai/data/institutional-holders/maplight-therapeutics-inc-56565p103) | COM | 729,929 | $26.2 million | -276,000 |
| [Capital One Finl Corp](https://specstream.ai/data/institutional-holders/capital-one-finl-corp-14040h105) | COM | 119,757 | $24 million | New |
| [Blue Owl Capital Corporation](https://specstream.ai/data/institutional-holders/blue-owl-capital-corporation-69121k104) | COM | 2,045,070 | $22.2 million | No change |
| [Deep Fission Inc](https://specstream.ai/data/institutional-holders/deep-fission-inc-243927100) | COM | 1,333,333 | $14.7 million | New |
| [Dell Technologies Inc](https://specstream.ai/data/institutional-holders/dell-technologies-inc-24703l202) | CL C | 32,961 | $14.2 million | +19,062 |
| [Holley Inc](https://specstream.ai/data/institutional-holders/holley-inc-43538h103) | COM | 4,376,888 | $11.2 million | +140,000 |
| [Eyepoint Inc](https://specstream.ai/data/institutional-holders/eyepoint-inc-30233g209) | COM NEW | 762,594 | $10.9 million | -150,000 |
| [Sagimet Biosciences Inc](https://specstream.ai/data/institutional-holders/sagimet-biosciences-inc-786700104) | COM SER A | 1,260,544 | $9.7 million | +926,667 |
| [Corvus Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/corvus-pharmaceuticals-inc-221015100) | COM | 608,600 | $9.1 million | +63,600 |
| [Artiva Biotherapeutics Inc](https://specstream.ai/data/institutional-holders/artiva-biotherapeutics-inc-04317a107) | COM | 874,542 | $8.5 million | New |
| [Compass Therapeutics Inc](https://specstream.ai/data/institutional-holders/compass-therapeutics-inc-20454b104) | COM | 3,624,076 | $7.9 million | +682,551 |
| [Conduent Inc](https://specstream.ai/data/institutional-holders/conduent-inc-206787103) | COM | 5,036,595 | $7.4 million | No change |
| [Rhythm Pharmaceuticals Inc](https://specstream.ai/data/institutional-holders/rhythm-pharmaceuticals-inc-76243j105) | COM | 61,455 | $6.8 million | No change |
| [Compass Pathways PLC](https://specstream.ai/data/institutional-holders/compass-pathways-plc-20451w101) | SPONSORED ADS | 450,000 | $6.4 million | New |
| [Ultragenyx Pharmaceutical in](https://specstream.ai/data/institutional-holders/ultragenyx-pharmaceutical-in-90400d108) | COM | 182,638 | $6.1 million | -120,000 |
| [Palvella Therapeutics Inc Ne](https://specstream.ai/data/institutional-holders/palvella-therapeutics-inc-ne-697947109) | COM | 36,259 | $5.5 million | +5,000 |
| [Imagenebio Inc](https://specstream.ai/data/institutional-holders/imagenebio-inc-45175g207) | COM | 917,692 | $5.4 million | -41,645 |
| Compass Pathways PLC | CALL (call) | 1,670,500 | $5.2 million | New |
| [Viridian Therapeutics Inc](https://specstream.ai/data/institutional-holders/viridian-therapeutics-inc-92790c104) | COM | 260,000 | $4.8 million | New |
| [Immix Biopharma Inc](https://specstream.ai/data/institutional-holders/immix-biopharma-inc-45258h106) | COM | 437,552 | $4.5 million | -110,000 |

## New positions in Q2 2026

23 positions not in the filing for the quarter ended March 31, 2026.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| [Space Exploration Techn Corp](https://specstream.ai/data/institutional-holders/space-exploration-techn-corp-84615q103) | CLASS A COM STK | 1,398,815 | $239 million |
| [Capital One Finl Corp](https://specstream.ai/data/institutional-holders/capital-one-finl-corp-14040h105) | COM | 119,757 | $24 million |
| [Deep Fission Inc](https://specstream.ai/data/institutional-holders/deep-fission-inc-243927100) | COM | 1,333,333 | $14.7 million |
| [Artiva Biotherapeutics Inc](https://specstream.ai/data/institutional-holders/artiva-biotherapeutics-inc-04317a107) | COM | 874,542 | $8.5 million |
| [Compass Pathways PLC](https://specstream.ai/data/institutional-holders/compass-pathways-plc-20451w101) | SPONSORED ADS | 450,000 | $6.4 million |
| Compass Pathways PLC | CALL (call) | 1,670,500 | $5.2 million |
| [Viridian Therapeutics Inc](https://specstream.ai/data/institutional-holders/viridian-therapeutics-inc-92790c104) | COM | 260,000 | $4.8 million |
| [Cabaletta Bio Inc](https://specstream.ai/data/institutional-holders/cabaletta-bio-inc-12674w109) | COM | 714,710 | $2.2 million |
| [Chime Finl Inc](https://specstream.ai/data/institutional-holders/chime-finl-inc-16935c109) | COM SHS CL A | 89,878 | $1.8 million |
| Erasca Inc | CALL (call) | 100,000 | $795,000 |
| [Cybin Inc](https://specstream.ai/data/institutional-holders/cybin-inc-23256x407) | COM NEW | 59,911 | $396,012 |
| Eledon Pharmaceuticals Inc | CALL (call) | 200,000 | $285,000 |
| Engene Therapeutics Inc | \*W EXP 10/31/202 | 511,177 | $148,190 |
| Larimar Therapeutics Inc | CALL (call) | 728,600 | $145,720 |
| [Celcuity Inc](https://specstream.ai/data/institutional-holders/celcuity-inc-15102k100) | COM | 1,249 | $130,670 |
| Compass Therapeutics Inc | CALL (call) | 303,800 | $106,330 |
| [Stablecoinx Inc](https://specstream.ai/data/institutional-holders/stablecoinx-inc-85238k118) | \*W EXP 06/25/203 | 250,000 | $102,500 |
| [Vodafone Group PLC](https://specstream.ai/data/institutional-holders/vodafone-group-plc-92857w308) | SPONSORED ADR | 5,371 | $71,005 |
| Murano Global Invt PLC | SHS | 261,875 | $62,850 |
| Alpha Modus Hldgs Inc | CL A NEW | 9,853 | $41,974 |
| [Zeo Energy Corp](https://specstream.ai/data/institutional-holders/zeo-energy-corp-98944f117) | \*W EXP 03/13/202 | 250,000 | $10,000 |
| [Livewire Group Inc](https://specstream.ai/data/institutional-holders/livewire-group-inc-53838j113) | \*W EXP 09/26/202 | 400,000 | $8,000 |
| [Nvni Group Limited](https://specstream.ai/data/institutional-holders/nvni-group-limited-g50716110) | \*W EXP 11/01/202 | 200,000 | $6,000 |

## Positions exited in Q2 2026

22 positions in the filing for the quarter ended March 31, 2026 and not in this one, with the shares and value reported then.

| Issuer | Class | Shares or principal | Value |
| --- | --- | --- | --- |
| Engene Holdings Inc | COM | 4,416,353 | $30.1 million |
| Compass Pathways PLC | CALL | 1,804,504 | $5.1 million |
| [Civeo Corp Cda](https://specstream.ai/data/institutional-holders/civeo-corp-cda-17878y207) | COM NEW | 180,475 | $4.8 million |
| Kalvista Pharmaceuticals Inc | COM | 215,000 | $4.3 million |
| [Ovid Therapeutics Inc](https://specstream.ai/data/institutional-holders/ovid-therapeutics-inc-690469101) | COM | 1,904,666 | $4.2 million |
| [Pliant Therapeutics Inc](https://specstream.ai/data/institutional-holders/pliant-therapeutics-inc-729139105) | COM | 2,969,199 | $3.7 million |
| Larimar Therapeutics Inc | CALL | 975,700 | $1.9 million |
| Engene Holdings Inc | \*W EXP 10/31/202 | 511,177 | $1.3 million |
| [Enterprise Prods Partners L](https://specstream.ai/data/institutional-holders/enterprise-prods-partners-l-293792107) | COM | 31,290 | $1.2 million |
| Syntec Optics Hldgs Inc | \*W EXP 99/99/999 | 803,132 | $867,383 |
| Mineralys Therapeutics Inc | CALL | 200,000 | $590,000 |
| Compass Therapeutics Inc | CALL | 400,000 | $500,000 |
| [Cardinal Health Inc](https://specstream.ai/data/institutional-holders/cardinal-health-inc-14149y108) | COM | 1,718 | $363,031 |
| Alpha Modus Hldgs Inc | CL A | 394,078 | $145,809 |
| Cid HOLDCO Inc | COM | 557,361 | $94,751 |
| Vodafone Group PLC | SPONSORED ADR | 5,371 | $80,672 |
| Viking Therapeutics Inc | CALL | 50,000 | $68,000 |
| Gohealth Inc | CL A NEW | 40,770 | $61,563 |
| Structure Therapeutics Inc | SPONSORED ADS | 100,000 | $25,000 |
| Olema Pharmaceuticals Inc | CALL | 200,000 | $10,000 |
| Bitcoin Depot Inc | \*W EXP 06/30/202 | 50,000 | $1,000 |
| Katapult Holdings Inc | \*W EXP 06/09/202 | 400,000 | $0 |

## Also on SpecStream

- [Blue Owl Capital Holdings LP Form 13F filing on EDGAR](https://www.sec.gov/Archives/edgar/data/1858703/000119312526345031/0001193125-26-345031-index.htm)
- [Largest 13F filers in New York](https://specstream.ai/data/institutional-holdings/state/new-york)
- [Largest institutional managers by 13F value](https://specstream.ai/data/institutional-holdings)
- [Most widely held securities in 13F filings](https://specstream.ai/data/institutional-holders)

Source: [the SEC's Form 13F data sets](https://www.sec.gov/data-research/sec-markets-data/form-13f-data-sets). Public data published by the US Securities and Exchange Commission (US government work). Managers report these holdings themselves in Form 13F, and the SEC does not check or guarantee them. Form 13F lists long positions in US listed equities, some options and convertible notes held at the end of the quarter, and leaves out short positions, cash, most bonds and holdings below the reporting threshold. Values are market values in US dollars as the manager filed them. A manager can ask the SEC to keep some positions confidential for a time. This page uses SEC data and is not endorsed or certified by the SEC.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in New York, New York

- [Home inspectors in New York, New York](https://specstream.ai/data/businesses/home-inspectors/new-york-new-york-united-states)
- [Roofing contractors in New York, New York](https://specstream.ai/data/businesses/roofing-contractors/new-york-new-york-united-states)
- [Cleaning companies in New York, New York](https://specstream.ai/data/businesses/cleaning-companies/new-york-new-york-united-states)
- [Language schools in New York, New York](https://specstream.ai/data/businesses/language-schools/new-york-new-york-united-states)
- [Telephone service providers in New York, New York](https://specstream.ai/data/businesses/telephone-service-providers/new-york-new-york-united-states)
- [Divorce and family law firms in New York, New York](https://specstream.ai/data/businesses/divorce-and-family-law-firms/new-york-new-york-united-states)
